Dr Manoj Raghavan graduated in Medicine from St George’s Hospital Medical School in 1994 and went on to train in Haematology at University College Hospital, London. He carried out his PhD at Barts and the London School of Medicine and Dentistry, completing his studies in 2008.

He was recruited to Birmingham in late 2010, taking up the post of Clinical Senior Lecturer at the University of Birmingham and Consultant Haematologist at University Hospitals Birmingham.

In December 2020, Manoj was appointed to the post of Precision Medicine Theme Lead for the Birmingham Experimental Cancer Medicine Centre (ECMC). Manoj is seeking to make early phase trials available to patients with targeted mutations, utilising clinical analysis of Next Generation Sequencing. He brings invaluable genomics expertise drawn from his role as chair of the West Midlands Genomic Tumour Advisory Board for Haemato-oncology, Sarcoma, Neuro-oncology, Paediatrics and Cancer of Unknown Primary.

He is a member of the NCRI Haemato-oncology MDS sub-group and is co-Chief Investigator on the REPAIR-MDS trial in low/intermediate risk MDS. Manoj is also chair of the British Society for Haematology Genomics Working Group, which aims to promote and provide guidelines and education to haematologists and biomedical scientists.